GAVI showcases innovative financing mechanisms to Convergence 2015

in page functions
[French]

Director of Programme Funding Team highlights benefits of GAVI business model to 200 of France’s leading development specialists

Marie-Ange Convergences 2015_thumb

Marie-Ange Sakara-Yao, Director of GAVI’s Programme Funding Team participates in a panel discussion at the annual Convergence 2012 meeting.

Paris, 19 September 2012 - Marie-Ange Sakara-Yao, Director of the GAVI Alliance’s Programme Funding Team this week attended France’s premier gathering of development professionals to explain how GAVI uses innovative financial tools to ensure all children have equal access to life-saving vaccines.

Addressing 200 participants, Ms. Saraka-Yao showcased the International Finance Facility for Immunisation (IFFIm), the Advance Market Commitment (AMC), and the Matching Fund.

"We need predictable funding over the long term. For example, the AMC has accelerated the production of new vaccines. We also involve stakeholders, encourage research, pulling prices down and finally diversify our funding sources,” she said.

Ms. Saraka-Yao was participating in the panel discussion "How to develop together economic models and innovative hybrid funding mechanisms” at the keynote Convergences 2015 conference. This annual event brings together the leading development professionals in France for three-days of discussion and debate.

Unacceptable

"Every 20 seconds a child dies from a disease that a vaccine could prevent. This is unacceptable," said Ms. Saraka-Yao.

"The goal of GAVI is to support the most vulnerable populations and developing countries so they can access vaccines. This includes strengthening immunisation coverage in developing countries with traditional vaccines, but also reducing the waiting time for people in developing countries to benefit from new vaccines."

To achieve its mission, our organisation must mobilise all its partners. Each brings its know-how and special skills.

Marie-Ange Sakara-Yao, Director of the GAVI Alliance’s Programme Funding Team

Business model

“To achieve its mission, our organisation must mobilise all its partners. Each brings its know-how and special skills which is an innovative business model and a strong symbol of unity for a common cause," said Ms. Saraka-Yao.

The GAVI Alliance brings together multilateral organisations, such as WHO, UNICEF and the World Bank, civil society organizations, public health agencies, governments of recipient and donor countries including France, private charitable foundations, such as The Bill & Melinda Gates Foundation and the Spanish "La Caixa", representatives of the pharmaceutical industry, including vaccine manufacturers, and financial institutions.

France

In conclusion, Ms. Saraka-Yao emphasised that "France is actively involved in GAVI’s aim to immunize 250 million children by 2015, the target date of the Millennium Development Goals, including MDG 4 on the reduction of child mortality.”

39%

Over the course of a decade, the weighted average price of pentavalent vaccine dropped by 39% from US$ 3.56 in 2003 to US$ 2.17 per dose in 2012, with a lowest ever price of US$ 1.19 per dose from one supplier in 2013.

GAVI Alliance 2013

More facts...

close icon

modal window here